CEO's repeated monthly sales of 15,000 shares suggest a pre-arranged 10b5-1 plan or routine compensation monetization. Monitor for any acceleration in selling volume or a Form 4 filing confirming execution. The small size relative to market cap limits immediate price impact.
Price Chart
Executive Summary
CEO Darren Sherman filed a Form 144 notice of intent to sell 15,000 shares of Orchestra BioMed common stock, valued at approximately $94,050 based on the filing date. The shares were acquired via restricted stock vesting on 11/25/2024 as compensation. This is a relatively small sale relative to typical insider holdings and the company's market cap, but the CEO's role and the filing's proximity to prior insider sales (July, August, September 2026) suggest a pattern of periodic monetization.
Key Facts
- CEO Darren Sherman filed Form 144 to sell 15,000 shares of common stock.
- Estimated value of proposed sale: ~$94,050 (based on 15,000 shares × ~$6.27/share).
- Shares were acquired via restricted stock vesting on 11/25/2024 as compensation.
- Sherman has sold 15,000 shares in each of the prior three months (July, August, September 2026).
- The filing is an advance notice of intent to sell; the actual sale may not occur.
Financial Impact
Proposed sale of 15,000 shares valued at ~$94,050 — approximately 0.02% of shares outstanding (est. 75M shares).
Risk Factors
- Insider selling pattern may signal lack of confidence if it accelerates beyond the current monthly cadence.
- Form 144 is only an intent to sell; the sale may not be executed.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-007169 |
| Document: 0001959173-26-007169-index.html | 0001959173-26-007169 |
| Document: 0001959173-26-007169.txt | 0001959173-26-007169 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 1, 2026 26d ago | 144 | $6.35 $5.73 | ▼ −9.76% | ▼ −11.06% | $5.55 (−12.60%) |
Oct 1, 2026 26d ago | 8-K | $6.35 $5.73 | ▼ −9.76% | ▼ −11.06% | $5.55 (−12.60%) |
Sep 22, 2026 4w ago | Institutional Cluster | $6.22 $6.08 | ▼ −2.25% | ▼ −1.06% | $5.55 (−10.77%) |
Sep 8, 2026 7w ago | Insider Cluster | $5.43 $6.04 | ▲ +11.23% | ▲ +12.35% | $5.55 (+2.21%) |
Sep 1, 2026 8w ago | 144 | $4.90 $5.45 | ▼ −11.22% | ▼ −11.14% | $5.55 (−13.27%) |
Jul 1, 2026 16w ago | 144 | $4.30 $3.96 | ▼ −7.91% | ▼ −8.17% | $5.55 (+29.07%) |
Jun 2, 2026 20w ago | Insider Cluster | $3.86 $4.02 | ▲ +4.15% | ▲ +7.96% | $5.55 (+43.78%) |
May 19, 2026 23w ago | Insider Cluster | $4.00 $4.06 | ▲ +1.50% | ▼ −0.75% | $5.55 (+38.75%) |
Apr 29, 2026 25w ago | DEFA14A | $3.99 $3.93 | ▼ −1.50% | ▼ −3.23% | $5.55 (+39.10%) |
Apr 23, 2026 26w ago | Press Release | $4.15 $3.80 | ▼ −8.43% | ▼ −9.91% | $5.55 (+33.73%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers